if there had been reasonable progress at KMP then the share price would probably not be so bad. if we had the full capacity 5200tpa online from mid-2022 (as originally scheduled) and offtake for the full amount i doubt we would be under 2$. instead we are still in commissioning and have sold 10t ndpr. our two offtakes have disappeared into the nether:
https://asm-au.com/asm-titanium-powder-approved-for-3d-printing-by-korean-advanced-manufacturing-company/ 1500tpa titanium powder
https://asmd.irmau.com/site/pdf/cd612574-b810-4cda-9a0c-028c01b370e0/Framework-Agmt-for-20-stake-in-Dubbo-Project-and-Offtake.pdf 2800tpa ndfeb 10 year offtake
the short campaign is just a product of poor management performance. if the company was doing well shorters would have a much harder time making money and therefore move on to other targets. instead they are here because asm sucks right now and have tied ourselves to the dead horse that is KCF for dubbo financing.
- Forums
- ASX - By Stock
- ASM
- The Short Report
ASM
australian strategic materials limited
Add to My Watchlist
2.88%
!
50.5¢

The Short Report, page-116
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
50.5¢ |
Change
-0.015(2.88%) |
Mkt cap ! $91.57M |
Open | High | Low | Value | Volume |
52.5¢ | 54.0¢ | 50.5¢ | $210.6K | 401.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 28242 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 778 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20000 | 0.505 |
13 | 143900 | 0.500 |
3 | 9020 | 0.495 |
2 | 12600 | 0.490 |
2 | 2100 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 778 | 1 |
0.525 | 10000 | 1 |
0.535 | 58947 | 2 |
0.540 | 26826 | 4 |
0.545 | 2756 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ASM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online